First Eagle Investment Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
2016
Q4
$108K Sell
2016
Q3
$656K Hold
2016
Q2
$377K Buy
2016
Q1
$381K Hold
2015
Q4
$666K Buy
2015
Q2
Sell
2015
Q1
$2.12M Buy
2014
Q3
Sell
2014
Q2
$7.72M Sell
2014
Q1
$8.15M Buy
2013
Q4
$4.62M Buy
2013
Q3
$4.69M Buy
2013
Q2
$2.02M Buy